Labshake search
Citations for Tocris :
651 - 700 of 1334 citations for 8H INDENO 1 2 D THIAZOL 2 AMINE HYDROBROMIDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: Antagonists were bath applied at the following concentrations: D-APV (Tocris Bioscience, 50μM), NBQX (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... currents were pharmacologically isolated by bath application of 50 µM D-APV (Tocris) and 50 µM CNQX (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and currents were pharmacologically isolated by bath application of 50μM D-APV (Tocris), 10 μM CNQX (Sigma) ...
-
bioRxiv - Neuroscience 2022Quote: ... Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-[1,3]dioxocino[6,5-d] pyrimidine-4,7,10,11,12-pentol (Tetrodotoxin: TTX) were purchased from Tocris Bioscience ...
-
bioRxiv - Cell Biology 2021Quote: ... and MRS2179 tetrasodium salt were obtained from Tocris (R&D Systems, Inc, Minneapolis, MN). Isradipine was purchased from Cayman Chemical Company (Ann Arbor ...
-
bioRxiv - Microbiology 2022Quote: ... 1ml of culture was incubated with the fluorescent D-amino acid HADA (Tocris Bioscience) at a final concentration of 250μM for 5 minutes ...
-
bioRxiv - Neuroscience 2021Quote: ... then reared in control rearing medium or medium supplemented with 100 µM D-serine (Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) was perfused through the probe at concentrations of 1 mM ...
-
bioRxiv - Cell Biology 2022Quote: ... coupled with cutaneous challenge with the Vitamin D analog MC903 (calcipotriol; 2700, Tocris, Bristol, UK) promotes esophageal eosinophilic infiltrates and food impactions (28 ...
-
bioRxiv - Microbiology 2022Quote: NADA (3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride) was synthesized by Tocris following the published protocol (31) ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were maintained in DMEM supplemented with 10% fetal bovine serum and D-APV (500 μM; Tocris) for 48 hrs before experiments.
-
bioRxiv - Neuroscience 2019Quote: ... NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM; Tocris, Cat# 0106) at the end of the recordings ...
-
bioRxiv - Developmental Biology 2020Quote: ... and FGF2 (100 ng/ml, R&D) in the presence or absence of retinoic acid (0.1 µM, Tocris). For paraxial mesoderm differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... In a subset of experiments the D1 receptor agonist (SKF81297; 20 mg/kg in saline; Tocris R&D systems), was injected intraperitoneally while recording cADDis photometry signals ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were then differentiated for 3 days (D) in N2B27 supplemented with 3 µM Chiron99021 (Tocris, Cat. No. 4953) and 20ng/ml bFGF (PeproTech ...
-
bioRxiv - Neuroscience 2023Quote: ... (5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801, 10 μM dissolved in H2O; Tocris Bioscience), 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 nM gastrin, 50 ng/ml recombinant human EGF (R&D, 236-EG) and 500 nM A83-01 (Tocris). Organoids were passaged every 4 days by physical dissociation using fire-polished Pasteur pipettes.
-
bioRxiv - Cell Biology 2024Quote: ... The following inhibitors were resuspended in DMSO and used at the final concentration as indicated: Actinomycin D (1.0 and 2.5 µg/ml; Tocris; 1229); Puromycin (10ug/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... Drug-evoked locomotor-like activities were induced by bath-applying 10 to 14 µM of N-methyl- D-aspartate (NMDA, Tocris) and serotonin (5-HT ...
-
bioRxiv - Neuroscience 2020Quote: ... Intrinsic properties were recorded in the presence of 10 μM biccuculine methiodide (Enzo, Life Sciences) and 10 μM saclofen (R&D, Tocris). We studied only cells with series resistance < 25 MΩ ...
-
bioRxiv - Developmental Biology 2020Quote: ... day 3 NMP-like cultures were treated with Accutase and replated at a density of 45,000 cells/cm2 on Geltrex-coated plates in N2B27 containing FGF2 (40 ng/ml, R&D) and CHIR99021 (8 µM, Tocris) for two days ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Cell Biology 2021Quote: ... The growth medium was supplemented with 100 ng/mL human recombinant epidermal growth factor (EGF) (R&D) as the major growth-supporting peptide and was further supplemented with 10 µM Y27632 (Tocris), 500 nM A83-01 (Tocris) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and plated at 60,000 cells/cm2 in N2B27 medium supplemented with 20 ng/ml of FGF2 (Cat# 233-FB/CF, R&D) and 4 μM of CHIR 99021 (Cat# 4423, Tocris) and 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5) and 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) were purchased from Tocris Bioscience or from HelloBio (UK) ...
-
bioRxiv - Cell Biology 2021Quote: ... 4 × 106 cells were seeded in a 21 cm2 dish and after 24 hours stimulated for ten minutes with 10 μM DAMGO ([D-Ala2, N-MePhe4, Gly-ol]-enkephalin, Tocris 1171) in DMEM medium (Sigma-Aldrich ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... supplemented with 100 ng/mL Activin A (R&D, Minneapolis, MN, USA) and 3–5 µM CHIR99021 (Tocris Bioscience, Bristol, UK) (differentiation day 0 ...
-
bioRxiv - Neuroscience 2022Quote: ... Intervet AB, Sweden), PCP (phencyclidine hydrochloride, 5 mg/kg, Lipomed AG, Switzerland) or amphetamine (d-amphetamine hydrochloride, 4 mg/kg, Tocris, UK) and recorded for another 60-120 minutes ...
-
bioRxiv - Neuroscience 2023Quote: ... all buffers and solutions used during the process (from animal perfusion to sorted cells flash freezing) were supplemented with a cocktail composed of Actinomycin D (3μM, Tocris #1229/10), Anisomycin (100 μM ...
-
bioRxiv - Immunology 2019Quote: ... and grown in B cell growth media to 80% confluence before being treated for 4h with 5μg/ml mitomycin C (Tocris, R&D Systems). Monolayers of growth arrested cells were washed 3 times with PBS ...
-
bioRxiv - Neuroscience 2022Quote: ... the medium was replaced with HBSS containing 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) at a concentration of 100 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... these experiments were performed in the presence of AMPA and NMDA receptor blockade (10 µM NBQX and 50 µM D-AP5 respectively; Tocris, Bristol, UK). To isolate excitatory currents ...
-
bioRxiv - Neuroscience 2023Quote: Adherent human iPSCs were grown to near confluence before the differentiation to heterogenous spinal/hindbrain neurons was initiated by changing the media for two days to media d1-2 (200 nM LDN193189 [Tocris, 6053], 10 µM SB431542 [Tocris, 1614], 25 ng/mL SHH-C25II [R&D Systems, 464-SH-025], 250 nM Purmorphamine [Tocris, 4551] ...
-
bioRxiv - Neuroscience 2023Quote: ... Drug treatments correspond to a single dose of cocaine hydrochloride at 20 mg/kg (Medisca, cat# 53-21-4, Canada) or D-amphetamine sulfate at 5 mg/kg (Tocris, 2813, UK) at doses known to increase locomotion87 ...
-
bioRxiv - Molecular Biology 2021Quote: ... 1 µM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 μM DMH-1 (Tocris) and 3 μM CHIR99021 (Tocris) ...
-
bioRxiv - Bioengineering 2023Quote: ... The supernatant was aspirated and the pellet re-suspended in fresh E8 medium supplemented with 10 µM ROCK inhibitor (Tocris R&D Systems). Re-suspended cells were seeded at a density between 7,500 – 12,500 cells / cm2 on fresh Matrigel-coated plates (Day – 3) ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1 μM IDE-1 and 1 μM XAV939 (both Tocris). 48 hours after the onset of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 μM endo-IWR-1 (Tocris), and 10 μM SB431542 (Stemgent).
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) on 6-well ECM collagen-I-coated peptide plates (Corning ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) and mixed with 90 μl Growth Factor Reduced Matrigel (Corning) ...
-
bioRxiv - Neuroscience 2019Quote: ... surgeries a single dose (0,6 mg/kg dissolved in phosphate buffer or saline) of P2Y12 receptor (P2Y12R) antagonist (PSB0739 Tocris, R&D Systems, Minneapolis, USA) was administered to the cisterna magna in 5 µl final volume using a glass capillary ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Cell Biology 2023Quote: ... naïve mGFP+ or YFP+ HFSCs were pretreated with the indicated antagonist (1nM UVI3003; 1uM HX531; 1uM JTE013; 100nM BMS 777607; 1uM AGN 193109) (first four: Tocris Bioscience; last one: R&D Systems) for 30 min prior to corpse or corpse-conditioned media addition ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...